Glucopath
Device CGM

Eversense PASS Program

Who it is for

Implantable CGM users with financial need; Medicare covers Eversense for insulin-dependent patients on MDI

What it covers

Affordable access to Eversense implantable CGM; Medicare covers it for eligible patients

What it costs you

Rough estimate reflecting wide cash-price variance across CGM brands, not program-specific.

Products covered

Eversense E3, Eversense 365

Eligibility

  • Implantable CGM users with financial need; Medicare covers Eversense for insulin-dependent patients on MDI
  • Insurance status: uninsured, medicare
  • Diabetes type: any
  • U.S. residency or citizenship documentation required
  • Available in: all

What you will need to apply

Use our universal document checklist.

Official links

Program website
Report an error

Glucopath is not medical or legal advice. Program rules change. Verify details with the program before you apply, and talk to your healthcare provider about your treatment.